Fcpm Iii Services B.v.
Latest statistics and disclosures from Fcpm Iii Services B.v.'s latest quarterly 13F-HR filing:
- Top 5 stock holdings are NAMS, DYN, ENGN, REPL, ENGNW, and represent 99.58% of Fcpm Iii Services B.v.'s stock portfolio.
- Added to shares of these 1 stock: DYN (+$49M).
- Reduced shares in these 2 stocks: ENGNW (-$5.2M), REPL.
- Fcpm Iii Services B.v. was a net buyer of stock by $44M.
- Fcpm Iii Services B.v. has $707M in assets under management (AUM), dropping by 108.49%.
- Central Index Key (CIK): 0002013410
Tip: Access up to 7 years of quarterly data
Positions held by Fcpm Iii Services B.v. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Fcpm Iii Services B.v.
Fcpm Iii Services B.v. holds 6 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 39.6 | $280M | 12M | 23.65 |
|
|
| Dyne Therapeutics (DYN) | 31.5 | $223M | +27% | 7.8M | 28.39 |
|
| Engene Holdings (ENGN) | 20.8 | $147M | 8.7M | 16.95 |
|
|
| Replimune Group (REPL) | 5.6 | $40M | 4.9M | 8.17 |
|
|
| Engene Holdings W Exp 10/31/2028 (ENGNW) | 2.1 | $15M | -25% | 2.9M | 5.20 |
|
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.4 | $3.0M | 2.4M | 1.25 |
|
Past Filings by Fcpm Iii Services B.v.
SEC 13F filings are viewable for Fcpm Iii Services B.v. going back to 2023
- Fcpm Iii Services B.v. 2024 Q1 filed May 3, 2024
- Fcpm Iii Services B.v. 2023 Q4 filed March 7, 2024